Status:
COMPLETED
Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)
Lead Sponsor:
ANRS, Emerging Infectious Diseases
Collaborating Sponsors:
Expertise France
Université Montpellier
Conditions:
HIV/AIDS
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This demonstration project will assess the acceptability and feasibility of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM) as part of a comprehensive HIV prevention package in com...
Detailed Description
This demonstration project will assess the acceptability and feasibility of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM) as part of a comprehensive HIV prevention package in com...
Eligibility Criteria
Inclusion
- Male (or transgender male person at birth)
- At least 18 years old
- HIV-seronegative
- Having had at least one anal sex episode with another man within the previous 6 months
- Having at least one of the following criteria:
- Have a sexual partner (male or female) infected with HIV without evidence of virological suppression
- Have had anal or vaginal sex episodes without condoms with more than one partner within the previous 6 months
- Have had a sexually-transmitted infection (STI) within the previous 6 months (syndromic or biological approach, or mentioned by the participant)
- Have received post-exposure prophylaxis for HIV within the previous 6 months
- Wishing to reinforce its means of prevention through the use of PrEP
- Accepting to participate in the study and signing the informed consent form
Exclusion
- Clinical manifestations suggesting a primary HIV infection
- Recent probable HIV exposure
- Creatinine clearance \<60 mL/min calculated according to the Cockroft \& Gault formula
- Positive or undetermined HBsAg
- Allergy or contraindication to any of the components of PrEP
- Participation in another biomedical and/or behavioral study on HIV or STIs (excluding CohMSM)
- Disability of the person making it difficult, if not impossible, to participate in the study or understanding of the information given to him
- Predictable non-compliance with the protocol (geographical distance, non-compliance with monitoring or other reasons)
Key Trial Info
Start Date :
November 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
649 Patients enrolled
Trial Details
Trial ID
NCT03459157
Start Date
November 20 2017
End Date
June 30 2021
Last Update
February 1 2024
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Oasis, Association African Solidarité
Ouagadougou, Burkina Faso
2
Clinique de Confiance, Espace Confiance
Abidjan, Côte d’Ivoire
3
Clinique des Halles, ARCAD-SIDA
Bamako, Mali
4
Centre Lucia, Espoir Vie Togo
Lomé, Togo